Compare Invesco DB Agriculture Fund (DBA) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco DB Agriculture Fund vs Sana Biotechnology Inc — how do they compare? Invesco DB Agriculture Fund trades at $27.82, while Sana Biotechnology Inc trades at $3.79 (market cap $1.13B). The key difference: Invesco DB Agriculture Fund is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| DBA | SANA | |
|---|---|---|
52-Week High | $28.73 | $5.92 |
52-Week Low | $25.44 | $2.68 |
Market Cap | — | $1.13B |
Sector | — | Health |
Enterprise Value | — | $1.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DBA trades at $27.79, down slightly by 0.11% today, while technical indicators show a bullish trend with strong moving average support. The fund has gained 5% over the past month, outperforming the S&P 500, driven by positive momentum in agricultural commodities. Recent news highlights consolidation near all-time highs and a 3.25% yield, though key financial ratios like P/E and P/S are unavailable for this ETF.
The outlook remains positive due to agricultural commodity strength and geopolitical factors, but risks include sector volatility and management fees. Investor sentiment is bolstered by recent performance and analyst buy ratings, yet dependence on commodity prices and global supply shocks pose significant downside risks for stockholders.
SANA Biotechnology trades at $3.77, up 4.43% today, with a bullish technical signal from moving averages and ADX indicators. The company reported a net loss of $244.17 million for 2025, with negative cash flow from operations, but analyst consensus is strongly positive with 82% buy ratings. Recent news highlights clinical data presentations and a $9.50 average price target from brokerages as of July 30, 2026.
The outlook hinges on clinical progress driving future profitability, but high cash burn and negative ROE pose significant risks. Upside potential exists if pipeline milestones are met, supported by institutional optimism, though investors face volatility from earnings misses and funding needs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Invesco DB Agriculture Fund
The index, which is comprised of one or more underlying commodities ("index commodities"), is intended to reflect the agricultural sector. The fund pursues its investment objective by investing in a portfolio of exchange-traded futures.
Read more on DBA →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
